The U.S. House of Representatives recently sent a letter to troubled blood analysis startup Theranos asking for an explanation of the company’s failure to offer accurate results to patients using its proprietary blood test technology.
Theranos developed a technique using its proprietary ‘Edison’ machine it claimed could detect hundreds of diseases using just one drop of blood. Read More
Theranos faces congressional inquiry over faulty blood tests
No comments:
Post a Comment